Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Premarket Approval (PMA)
  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
Note: this medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original PMA or panel track supplement and may not represent the most recent labeling.
 
DeviceLINX REFLUX MANAGEMENT SYSTEM
Generic NameIMPLANT, ANTI-GASTROESOPHAGEAL REFLUX
ApplicantTORAX MEDICAL
4545 Creek Rd
Cincinnati, OH 45242
PMA NumberP100049
Date Received12/30/2010
Decision Date03/22/2012
Product Code LEI 
Docket Number 12M-0893
Notice Date 08/14/2012
Advisory Committee Gastroenterology/Urology
Clinical TrialsNCT00776997
Expedited Review Granted? No
Combination ProductNo
RecallsCDRH Recalls
Approval Order Statement  
APPROVAL FOR THE LINX REFLUX MANAGEMENT SYSTEM. THIS DEVICE IS INDICATED FOR PATIENTS DIAGNOSED WITH GASTROESOPHAGEAL REFLUX DISEASE (GERD) AS DEFINED BY ABNORMAL PH TESTING, AND WHO CONTINUE TO HAVE CHRONIC GERD SYMPTOMS DESPITE MAXIMUM THERAPY FOR THE TREATMENT OF REFLUX.
Approval OrderApproval Order
SummarySummary of Safety and Effectiveness
LabelingLabeling
Post-Approval StudyShow Report Schedule and Study Progress
Supplements:  S001 S002 S003 S004 S005 S006 S007 S008 S009 S010 S011 
S012 S013 S014 S015 S016 S017 S018 S019 S020 S021 S022 S023 
S024 S025 S026 S027 S028 S029 S030 S031 S032 S033 S034 S035 
S036 S037 
-
-